MANGIACAPRA, FABIO
 Distribuzione geografica
Continente #
AS - Asia 4.913
NA - Nord America 1.363
EU - Europa 634
SA - Sud America 148
OC - Oceania 41
AF - Africa 21
Totale 7.120
Nazione #
SG - Singapore 4.088
US - Stati Uniti d'America 1.316
CN - Cina 429
IT - Italia 264
HK - Hong Kong 148
BR - Brasile 102
VN - Vietnam 81
GB - Regno Unito 70
DE - Germania 67
FR - Francia 57
IN - India 44
NL - Olanda 43
AU - Australia 40
CZ - Repubblica Ceca 40
BD - Bangladesh 23
CA - Canada 21
AR - Argentina 20
ID - Indonesia 15
MX - Messico 15
FI - Finlandia 12
EC - Ecuador 11
PH - Filippine 11
RU - Federazione Russa 10
IR - Iran 9
PK - Pakistan 9
PL - Polonia 9
TR - Turchia 9
ZA - Sudafrica 9
JP - Giappone 8
BE - Belgio 7
MY - Malesia 6
CO - Colombia 5
IQ - Iraq 5
LT - Lituania 5
MD - Moldavia 5
RO - Romania 5
UA - Ucraina 5
DO - Repubblica Dominicana 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CL - Cile 3
ES - Italia 3
JM - Giamaica 3
NO - Norvegia 3
NP - Nepal 3
RS - Serbia 3
SE - Svezia 3
TN - Tunisia 3
TW - Taiwan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
HU - Ungheria 2
LU - Lussemburgo 2
MA - Marocco 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
FJ - Figi 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
MQ - Martinica 1
NI - Nicaragua 1
PY - Paraguay 1
SA - Arabia Saudita 1
SD - Sudan 1
SI - Slovenia 1
SL - Sierra Leone 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.120
Città #
Ashburn 469
San Jose 308
Singapore 294
Rome 166
Hong Kong 146
Dallas 126
Beijing 109
Hefei 102
Boardman 65
London 46
Lauterbourg 45
Munich 31
Amsterdam 30
Brno 27
Shanghai 26
Ho Chi Minh City 24
Los Angeles 24
Perth 22
Council Bluffs 21
New York 20
Hanoi 18
San Francisco 16
West Jordan 16
Santa Clara 14
Milan 11
Seattle 11
Olomouc 10
Mexico City 9
Orem 9
Bengaluru 8
Montreal 8
Shenzhen 8
Washington 8
Frankfurt am Main 7
Johannesburg 7
Manchester 7
Melbourne 7
Bocholt 6
Brooklyn 6
Helsinki 6
Warsaw 6
Bologna 5
Chennai 5
Da Nang 5
Karachi 5
Nuremberg 5
Pune 5
Surat 5
São Paulo 5
Tokyo 5
Turku 5
Xi'an 5
Atlanta 4
Guayaquil 4
Hanover 4
Porto Alegre 4
Quezon City 4
Quận Ninh Kiều 4
Shijiazhuang 4
Târgu Mureş 4
Zhengzhou 4
Zhoukou 4
Aubin Grove 3
Bandung 3
Boston 3
Buffalo 3
Campinas 3
Chicago 3
Conroe 3
George Town 3
Guangzhou 3
Haiphong 3
Miami 3
Palermo 3
Philadelphia 3
Quilmes 3
Quito 3
Rio de Janeiro 3
Santo Domingo 3
Stuttgart 3
Taipei 3
Thrissur 3
Toronto 3
Aberdeen 2
Abu Dhabi 2
Ambāla 2
Ankara 2
Armenia 2
Aversa 2
Baku 2
Belgrade 2
Belo Horizonte 2
Borås 2
Brasília 2
Buon Ma Thuot 2
Bắc Ninh 2
Castagnole 2
Catania 2
Ciampino 2
Conselheiro Lafaiete 2
Totale 2.491
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 442
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 269
Current management and prognosis of patients with recurrent myocardial infarction 239
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 237
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 235
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 234
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 229
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 225
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 223
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 218
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 213
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients) 207
Gender-Based Specificities of Fractional Flow Reserve Measurement 202
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 201
Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure 200
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. 196
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 192
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 172
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention 161
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 143
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 142
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 134
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 130
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 129
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 120
High value of mid-regional proadrenomedullin in COVID-19: A marker of widespread endothelial damage, disease severity, and mortality 119
Effects of ticagrelor and prasugrel on coronary microcirculation in elective percutaneous coronary intervention 118
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 116
Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention 116
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 115
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 113
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 113
Invasive Assessment of Coronary Microvascular Function 107
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 100
CARDIAC ANTHRACYCLINE ACCUMULATION AND B-TYPE NATRIURETIC PEPTIDE TO DEFINE RISK AND PREDICTORS OF CANCER TREATMENT RELATED EARLY DIASTOLIC DYSFUNCTION 98
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 96
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 90
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis 83
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 77
Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients 66
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 62
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 60
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 59
Impact of Tourniquet Use on Systemic Inflammatory Parameters, Functional Physical Recovery, and Cardiovascular Outcomes of Patients Undergoing Knee Arthroplasty: A Case-Control Study 59
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 55
Natural History of Coronary Atherosclerosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: The Role of Quantitative Flow Ratio 53
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 51
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 43
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 40
Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention 40
Idiopathic sensorineural hearing loss is associated with endothelial dysfunction 32
Totale 7.174
Categoria #
all - tutte 24.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 2 3 0 0 0 0 0 0 7 43
2022/202369 2 2 5 9 12 0 0 3 2 0 34 0
2023/2024555 3 18 17 26 14 71 33 265 31 28 10 39
2024/20254.343 54 17 72 30 25 67 58 35 113 259 1.695 1.918
2025/20262.152 185 170 160 209 114 131 524 138 165 233 120 3
Totale 7.174